The potential clinical utility of cell-free DNA for gastric cancer patients treated with nivolumab monotherapy

MLA

Chiaki Inagaki, et al. “The Potential Clinical Utility of Cell-Free DNA for Gastric Cancer Patients Treated with Nivolumab Monotherapy.” Scientific Reports, vol. 13, no. 1, Apr. 2023, pp. 1–12. EBSCOhost, https://doi.org/10.1038/s41598-023-32645-x.

APA

Chiaki Inagaki, Hisato Kawakami, Daichi Maeda, Daisuke Sakai, Shinya Urakawa, Kentaro Nishida, Toshihiro Kudo, Yuichiro Doki, Hidetoshi Eguchi, Hisashi Wada, & Taroh Satoh. (2023). The potential clinical utility of cell-free DNA for gastric cancer patients treated with nivolumab monotherapy. Scientific Reports, 13(1), 1–12. https://doi.org/10.1038/s41598-023-32645-x

Chicago

Chiaki Inagaki, Hisato Kawakami, Daichi Maeda, Daisuke Sakai, Shinya Urakawa, Kentaro Nishida, Toshihiro Kudo, et al. 2023. “The Potential Clinical Utility of Cell-Free DNA for Gastric Cancer Patients Treated with Nivolumab Monotherapy.” Scientific Reports 13 (1): 1–12. doi:10.1038/s41598-023-32645-x.